Zions Bancorporation NA
F:ZB1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zions Bancorporation NA
F:ZB1
|
US |
|
Adial Pharmaceuticals Inc
NASDAQ:ADIL
|
US |
|
T
|
Talanx AG
XHAM:TLX
|
DE |
|
Verisign Inc
NASDAQ:VRSN
|
US |
|
Infosys Ltd
F:IOY
|
IN |
|
W
|
Wiit SpA
MIL:WIIT
|
IT |
|
Unicharm Corp
TSE:8113
|
JP |
|
China Coal Energy Co Ltd
OTC:CCOZY
|
CN |
|
S
|
Sanofi SA
XETRA:SNW
|
FR |
Wall St Price Targets
ZB1 Price Targets Summary
Zions Bancorporation NA
According to Wall Street analysts, the average 1-year price target for ZB1 is 45.67 EUR with a low forecast of 40.67 EUR and a high forecast of 55.04 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZB1's stock price target?
Price Target
45.67
EUR
According to Wall Street analysts, the average 1-year price target for ZB1 is 45.67 EUR with a low forecast of 40.67 EUR and a high forecast of 55.04 EUR.
What is the Revenue forecast for Zions Bancorporation NA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Zions Bancorporation NA?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 4%.
